Literature DB >> 31529280

Central nervous system (CNS) enterovirus infections: A single center retrospective study on clinical features, diagnostic studies, and outcome.

Sarah D Torres1, Dan Tong Jia2, Emily M Schorr3, Brian L Park4, Alexandra Boubour5, Amelia Boehme1, Jyoti V Ankam6, Jacqueline S Gofshteyn7, Charles Tyshkov7, Daniel A Green8, Wendy Vargas1, Jason Zucker9, Anusha K Yeshokumar3, Kiran T Thakur10,11.   

Abstract

Enteroviruses (EV) are responsible for a large number of meningoencephalitis cases, especially in children. The objective of this study was to identify modes of diagnosis including the significance of respiratory and cerebrospinal fluid samples, associated clinical characteristics, inpatient management, and outcome of individuals with EV infections of the central nervous system (CNS). Electronic medical records of individuals with enterovirus infections of the CNS who presented to the Columbia University Irving Medical Center and Children's Hospital of New York between January 1, 2012 and December 31, 2017 were reviewed retrospectively for demographic, epidemiological, and clinical data. The median age overall was 1.7 months (interquartile range 14 years) and most (62.4%) were male. The majority of CNS infections presented as meningitis (95.7%) and occurred in the summer (45.2%) and fall seasons (37.6%). Eighty-five cases (91.4%) demonstrated EV positivity in cerebrospinal fluid, thirty cases (32.3%) exhibited both cerebrospinal fluid and respiratory positivity, and eight cases (8.6%) exhibited respiratory positivity with coinciding neurological findings. Eighty-nine individuals overall (95.7%) received antibiotics and 37 (39.8%) received antiviral treatment. All surviving individuals had favorable Modified Rankin Scores (MRS) within the zero to two ranges upon discharge. Testing respiratory samples in addition to cerebrospinal fluid was found to be an important diagnostic tool in EV-associated cases. While clinical outcomes were favorable for an overwhelming majority of cases, etiological understanding of CNS infections is essential for identifying ongoing and changing epidemiological patterns and aid in improving the diagnosis and treatment.

Entities:  

Keywords:  Acute flaccid myelitis; Central nervous system infections; Enterovirus; Neurodiagnostics; Pediatrics

Year:  2019        PMID: 31529280      PMCID: PMC7235972          DOI: 10.1007/s13365-019-00784-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  22 in total

Review 1.  Picornavirus infections: a primer for the practitioner.

Authors:  H A Rotbart; F G Hayden
Journal:  Arch Fam Med       Date:  2000 Sep-Oct

Review 2.  Enterovirus Infections of the Central Nervous System in Children: An Update.

Authors:  Henriette Rudolph; Horst Schroten; Tobias Tenenbaum
Journal:  Pediatr Infect Dis J       Date:  2016-05       Impact factor: 2.129

3.  Analysis of enterovirus types in patients with symptoms of aseptic meningitis in 2014 in Shandong, China.

Authors:  Peng Chen; Xiaojuan Lin; Guifang Liu; Suting Wang; Lizhi Song; Zexin Tao; Aiqiang Xu
Journal:  Virology       Date:  2018-03       Impact factor: 3.616

4.  Evaluating the Brighton Collaboration case definitions, aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis, by systematic analysis of 255 clinical cases.

Authors:  Barbara Rath; Manya Magnus; Ulrich Heininger
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

Review 5.  Human picornaviruses associated with neurological diseases and their neutralization by antibodies.

Authors:  Maria Anastasina; Aušra Domanska; Kaia Palm; Sarah Butcher
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

6.  Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens.

Authors:  Laura Kupila; Tytti Vuorinen; Raija Vainionpäā; Reijo J Marttila; Pirkko Kotilainen
Journal:  Clin Infect Dis       Date:  2005-03-04       Impact factor: 9.079

Review 7.  Viral Meningitis and Encephalitis.

Authors:  Jennifer L Lyons
Journal:  Continuum (Minneap Minn)       Date:  2018-10

8.  Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge.

Authors:  Carlos M Pérez-Vélez; Marsha S Anderson; Christine C Robinson; Elizabeth J McFarland; W Allan Nix; Mark A Pallansch; M Steven Oberste; Mary P Glodé
Journal:  Clin Infect Dis       Date:  2007-09-13       Impact factor: 9.079

9.  Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery.

Authors:  Jun Han; Xue-Jun Ma; Jun-Feng Wan; Ying-Hui Liu; Yan-Ling Han; Cao Chen; Chan Tian; Chen Gao; Miao Wang; Xiao-Ping Dong
Journal:  BMC Infect Dis       Date:  2010-06-18       Impact factor: 3.090

10.  The emergence of enterovirus D68 in England in autumn 2014 and the necessity for reinforcing enterovirus respiratory screening.

Authors:  A I Carrion Martin; R G Pebody; K Danis; J Ellis; S Niazi; S DE Lusignan; K E Brown; M Zambon; D J Allen
Journal:  Epidemiol Infect       Date:  2017-04-03       Impact factor: 4.434

View more
  2 in total

1.  Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis.

Authors:  Anne Piantadosi; Shibani S Mukerji; Simon Ye; Tracey A Cho; Pardis Sabeti; Michael J Leone; Lisa M Freimark; Daniel Park; Gordon Adams; Jacob Lemieux; Sanjat Kanjilal; Isaac H Solomon; Asim A Ahmed; Robert Goldstein; Vijay Ganesh; Bridget Ostrem; Kaelyn C Cummins; Jesse M Thon; Cormac M Kinsella; Eric Rosenberg; Matthew P Frosch; Marcia B Goldberg
Journal:  mBio       Date:  2021-08-31       Impact factor: 7.867

2.  Neurological complications of varicella zoster virus reactivation: Prognosis, diagnosis, and treatment of 72 patients with positive PCR in the cerebrospinal fluid.

Authors:  Tiphaine Lenfant; Anne-Sophie L'Honneur; Brigitte Ranque; Benoit Pilmis; Caroline Charlier; Mathieu Zuber; Jacques Pouchot; Flore Rozenberg; Adrien Michon
Journal:  Brain Behav       Date:  2022-01-18       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.